Literature DB >> 11095591

Chemoenzymatic preparation of silybin beta-glucuronides and their biological evaluation.

V Kren1, J Ulrichová, P Kosina, D Stevenson, P Sedmera, V Prikrylová, P Halada, V Simánek.   

Abstract

Chemoenzymatic glucuronidation of the optically pure silybin A (1) using ovine liver glucuronyl transferase afforded three beta-glucuronides of silybin, substituted at phenolic OH groups at the positions C-20 (2), C-7 (3), and C-5 (4) formed in the yields 27, 62.5, and 2.5%, respectively. Using these standards, it was shown that the main silybin conjugate in humans is its 20-beta-D-glucuronate (2), while the C-7 regioisomer (3) was formed in lower proportion. The rate of conjugation of (natural) silybin diastereomers 10S, 11S and 10R, 11R, and therefore also their metabolism in humans is rather different. The radical scavenging activity of 2 is considerably lower than that of its aglycone (1); however, the activity of 3 is higher than in the silybin. These findings corroborate the hypothesis that, at physiological pH, the exclusive target for one-electron oxidation of the silybin molecule is the o-methoxy-phenolic structure at C-19, C-20. This is first pharmacological study using optically pure silybin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095591

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

Review 1.  Compounds isolated at the Institute of Microbiology in 1989-2001 and future trends.

Authors:  T Rezanka; J Spizek
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

2.  Chemoenzymatic Synthesis, Characterization, and Scale-Up of Milk Thistle Flavonolignan Glucuronides.

Authors:  Brandon T Gufford; Tyler N Graf; Noemi D Paguigan; Nicholas H Oberlies; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2015-08-27       Impact factor: 3.922

Review 3.  Herb-drug interactions: a literature review.

Authors:  Zeping Hu; Xiaoxia Yang; Paul Chi Lui Ho; Sui Yung Chan; Paul Wan Sia Heng; Eli Chan; Wei Duan; Hwee Ling Koh; Shufeng Zhou
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.

Authors:  Luciana G Naso; Evelina G Ferrer; Nataliya Butenko; Isabel Cavaco; Luis Lezama; Teófilo Rojo; Susana B Etcheverry; Patricia A M Williams
Journal:  J Biol Inorg Chem       Date:  2011-03-12       Impact factor: 3.358

5.  Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C.

Authors:  Roy L Hawke; Sarah J Schrieber; Tedi A Soule; Zhiming Wen; Philip C Smith; K Rajender Reddy; Abdus S Wahed; Steven H Belle; Nezam H Afdhal; Victor J Navarro; Josh Berman; Qi-Ying Liu; Edward Doo; Michael W Fried
Journal:  J Clin Pharmacol       Date:  2009-10-19       Impact factor: 3.126

6.  HiFSA fingerprinting applied to isomers with near-identical NMR spectra: the silybin/isosilybin case.

Authors:  José G Napolitano; David C Lankin; Tyler N Graf; J Brent Friesen; Shao-Nong Chen; James B McAlpine; Nicholas H Oberlies; Guido F Pauli
Journal:  J Org Chem       Date:  2013-03-05       Impact factor: 4.354

7.  Ultrasonic-assisted enzymatic extraction of silymarin from the Silybum marianum seed shell and evaluation of its antioxidant activity in vitro.

Authors:  Fei Zhao; XinHua Li
Journal:  EXCLI J       Date:  2015-07-27       Impact factor: 4.068

Review 8.  Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.

Authors:  Michal Bijak
Journal:  Molecules       Date:  2017-11-10       Impact factor: 4.411

9.  Sulfated Metabolites of Flavonolignans and 2,3-Dehydroflavonolignans: Preparation and Properties.

Authors:  Kateřina Valentová; Kateřina Purchartová; Lenka Rydlová; Lenka Roubalová; David Biedermann; Lucie Petrásková; Alena Křenková; Helena Pelantová; Veronika Holečková-Moravcová; Eva Tesařová; Josef Cvačka; Jiří Vrba; Jitka Ulrichová; Vladimír Křen
Journal:  Int J Mol Sci       Date:  2018-08-09       Impact factor: 5.923

10.  Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLD.

Authors:  Ying Xie; Sonia R Miranda; Janelle M Hoskins; Roy L Hawke
Journal:  Molecules       Date:  2017-01-15       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.